Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-20 4:15 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 4,085,544 5.1% | 4,085,544 (New Position) | View |
| 2023-06-26 4:30 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management L.P. | 11,427,517 8.9% | 10,318,333 (+930.26%) | View |
| 2023-06-01 5:00 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management L.P. | 3,562,902 5% | 3,562,902 (New Position) | View |
| 2023-05-24 5:15 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | Point72 Asset Management L.P. | 2,121,170 8.7% | 2,121,170 (New Position) | View |
| 2023-05-16 4:02 pm Purchase | 13G | CUTERA INC CUTR | Point72 Asset Management L.P. | 1,144,407 5.8% | 1,144,407 (New Position) | View |
| 2023-04-05 4:23 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | Point72 Asset Management L.P. | 4,533,756 5% | 2,095,618 (+85.95%) | View |
| 2023-03-09 4:17 pm Purchase | 13G | CEPTON INC CPTN | Point72 Asset Management L.P. | 1,815,228 1.2% | 1,815,228 (New Position) | View |
| 2023-02-23 7:43 pm Purchase | 13G | INARI MED INC NARI | Point72 Asset Management L.P. | 2,795,352 5.2% | 2,795,352 (New Position) | View |
| 2023-02-17 4:35 pm Purchase | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | Point72 Asset Management L.P. | 8,114,890 5% | 8,114,890 (New Position) | View |
| 2023-02-14 4:27 pm Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Point72 Asset Management L.P. | 3,114,107 6.7% | 1,131,546 (+57.07%) | View |
| 2023-02-14 4:25 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Point72 Asset Management L.P. | 3,515,356 7.1% | 116,695 (+3.43%) | View |
| 2023-02-14 4:23 pm Purchase | 13G | GRITSTONE BIO INC GRTS | Point72 Asset Management L.P. | 7,702,831 9.2% | 1,094,273 (+16.56%) | View |
| 2023-02-14 4:23 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management L.P. | 3,868,006 5.4% | -450,034 (-10.42%) | View |
| 2023-02-14 4:22 pm Purchase | 13G | FIBROGEN INC FGEN | Point72 Asset Management L.P. | 6,281,645 6.7% | 1,615,538 (+34.62%) | View |
| 2023-02-14 4:22 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management L.P. | 500,737 5.3% | 500,737 (New Position) | View |
| 2023-02-14 4:21 pm Sale | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management L.P. | 2,124,200 7.5% | -157,000 (-6.88%) | View |
| 2023-02-14 4:20 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | Point72 Asset Management L.P. | 1,150,648 7.4% | 189,778 (+19.75%) | View |
| 2023-02-14 4:20 pm Purchase | 13G | EOS ENERGY ENTERPRISES INC EOSE | Point72 Asset Management L.P. | 5,535,030 6.7% | 2,493,265 (+81.97%) | View |
| 2023-02-14 4:19 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | Point72 Asset Management L.P. | 69,450 0.1% | -1,984,767 (-96.62%) | View |
| 2023-02-14 4:19 pm Sale | 13G | XENON PHARMACEUTICALS INC XENE | Point72 Asset Management L.P. | 1,178,501 1.9% | -1,828,637 (-60.81%) | View |